<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>小药说药 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-08T07:42:44+08:00</updated>
  <subtitle>姓药的来说药，带你进入最深层次的医药领域，把握医药动态，了解最新前沿！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>新的策略来定义Tregs！</title>
    <updated>2021-01-08T06:28:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/bFKrwewARU7uqosb-O_wlg</id>
    <link href="https://mp.weixin.qq.com/s/bFKrwewARU7uqosb-O_wlg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>求职，非诚勿扰，有意者联系本人</title>
    <updated>2021-01-05T08:16:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/p2ZtxsL6eW64SZMj09rzCw</id>
    <link href="https://mp.weixin.qq.com/s/p2ZtxsL6eW64SZMj09rzCw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>耐受性树突状细胞：治疗自身免疫和炎症性疾病的新手段</title>
    <updated>2021-01-04T06:11:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/FrslovlR854gfTXd_nzHhg</id>
    <link href="https://mp.weixin.qq.com/s/FrslovlR854gfTXd_nzHhg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>溶瘤病毒 + CAR-T，治疗实体瘤的新组合靠谱吗？</title>
    <updated>2021-01-02T06:29:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/i9P6pImW23QRhtYk7BKEkA</id>
    <link href="https://mp.weixin.qq.com/s/i9P6pImW23QRhtYk7BKEkA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>回首2020年的健康故事</title>
    <updated>2020-12-31T06:11:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/jsGOKEsNVUHTlUtvSlu8kw</id>
    <link href="https://mp.weixin.qq.com/s/jsGOKEsNVUHTlUtvSlu8kw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>多临床数据的ADC免疫原性观察</title>
    <updated>2020-12-29T06:18:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/xtIf5-JRj6E2rwbwC_-ZWw</id>
    <link href="https://mp.weixin.qq.com/s/xtIf5-JRj6E2rwbwC_-ZWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国际多中心临床试验的成功要素</title>
    <updated>2020-12-27T06:27:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/2kOeCOSRC6YSL-B4guF20g</id>
    <link href="https://mp.weixin.qq.com/s/2kOeCOSRC6YSL-B4guF20g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“变节”的NK细胞：蜕膜样NK细胞极化</title>
    <updated>2020-12-25T06:26:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/JwJu7ucxLItf3hAgSZGeOg</id>
    <link href="https://mp.weixin.qq.com/s/JwJu7ucxLItf3hAgSZGeOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>癌症研究蓝图：精准医学的关键差距与机遇</title>
    <updated>2020-12-23T06:00:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/vFcrVbyIF4pEE_oksu9ipQ</id>
    <link href="https://mp.weixin.qq.com/s/vFcrVbyIF4pEE_oksu9ipQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤突变负荷作为免疫治疗生物标志物的挑战</title>
    <updated>2020-12-21T06:36:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/zU5pzzbjeXDO5VMwacmYLw</id>
    <link href="https://mp.weixin.qq.com/s/zU5pzzbjeXDO5VMwacmYLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>